Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 160

Mitsui and Siemens fuel $60m series D for Lanzatech

The sustainable energy and fuels producer has raised $60m in a round also featuring the corporate venturing arms of Siemens and CICC.

Mar 27, 2014

GE Pension Trust helps Verdasys unlock funding

Data security firm Verdasys has taken its overall funding past $65m with a round backed by GE Pension Trust

Mar 25, 2014

Alibaba joins the Tango dance with $215m investment

The free mobile communication service, which has secured funding from Qualcomm and Access Industries in the past, has raised $280m in its latest venture round.

Mar 21, 2014

LED lighting company Glo closes $30m series D round

The Sweden-based company, which uses nanotechnology to develop next-generation lighting products, counts Agder Energi Ventures among its existing investors.

Mar 20, 2014

Novo leads ZSPharma to better health

ZS Pharma, a specialty pharmaceutical company developing novel treatments for kidney, cardiovascular, and liver disorders, has completed a $55m series D financing. The investor syndicate was led by Novo A/S and included new investors RA Capital, Adage Capital, Sofinnova Ventures ,and an undisclosed institutional investor. The company has raised $103m to date.

Mar 15, 2014

Susquehanna leads Payoneer funding

Online payments company Payoneer raises series D financing round of $25m, led by Susquehanna Growth Equity, to "transform the way small businesses around the world get paid for selling products and services across borders".

Mar 11, 2014

EBay back for Snapdeal

Online marketplace eBay leads $133.8m in series D funding for Indian peer Snapdeal.com.

Mar 4, 2014

JAIC, Nippon treat Regimmune to $9.2m series D

Japan Asia Investment Corporation (JAIC) and Nippon Venture Capital Corp (NVCC) have led a $9.2m series D round of funding for Regimmune, a Japanese biotechnology company focused on the discovery, development and commercialisation of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, auto-immune diseases and transplantation.

Feb 20, 2014

Johnson & Johnson eyes another round for PowerVision

Existing investors Venrock, Johnson & Johnson Development Corp., Medtronic, Advanced Technology Ventures, Lexington Capital and Frazier Healthcare Ventures have invested in a first tranche of a series D round of funding for PowerVision. The company is developing an accommodating intraocular lens. The company plans to raise up to an additional $10m as part of this $20m financing round.

Feb 11, 2014
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here